Kilitch Net Income Applicable To Common Shares from 2010 to 2024

KILITCH Stock   307.55  0.10  0.03%   
Kilitch Drugs' Net Income Applicable To Common Shares is increasing with slightly volatile movements from year to year. Net Income Applicable To Common Shares is estimated to finish at about 126.2 M this year. Net Income Applicable To Common Shares is the net income that remains after preferred dividends have been deducted, available to common shareholders. View All Fundamentals
 
Net Income Applicable To Common Shares  
First Reported
2014-06-30
Previous Quarter
33.6 M
Current Value
47.4 M
Quarterly Volatility
21 M
 
Yuan Drop
 
Covid
Check Kilitch Drugs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kilitch Drugs' main balance sheet or income statement drivers, such as Depreciation And Amortization of 32.6 M, Interest Expense of 62.3 M or Selling General Administrative of 25 M, as well as many indicators such as . Kilitch financial statements analysis is a perfect complement when working with Kilitch Drugs Valuation or Volatility modules.
  
This module can also supplement various Kilitch Drugs Technical models . Check out the analysis of Kilitch Drugs Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Kilitch Stock

Kilitch Drugs financial ratios help investors to determine whether Kilitch Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kilitch with respect to the benefits of owning Kilitch Drugs security.